The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Neuroblastoma: Biology, Prognosis, and Treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Pathology of Tumours of the Nervous System
(1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199001000-00011 · Cited by 3,472
Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V, Castelberry, R. P., De Bernardi, B., Evans, A. E., Favrot, M., & Hedborg, F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1466 · Cited by 2,294
Neuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Maris, J. M., Hogarty, M. D., Bagatell, R., & Cohn, S. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60983-0 · Cited by 2,032
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Cohn, S. L., Pearson, A. D. J., London, W. B., Monclair, T., Ambros, P. F., Brodeur, G. M., Faldum, A., Hero, B., Iehara, T., Machin, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6785 · Cited by 1,910
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
The Hedgehog and Wnt signalling pathways in cancer
Taipale, J., & Beachy, P. A. (2001) · Nature · doi:10.1038/35077219 · Cited by 1,393
The Trk family of neurotrophin receptors
Barbacid, M. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251107 · Cited by 1,281
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Monclair, T., Brodeur, G. M., Ambros, P. F., Brisse, H. J., Cecchetto, G., Holmes, K., Kaneko, M., London, W. B., Matthay, K. K., Nuchtern, J. G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6876 · Cited by 1,150
The International Neuroblastoma Pathology Classification (the Shimada system)
Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J.-I., Joshi, V. V., Roald, B., Stram, D. O., Gerbing, R. B., Lukens, J. N., Matthay, K. K., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<364::aid-cncr21>3.0.co;2-7 · Cited by 1,067
Oncogenic mutations of ALK kinase in neuroblastoma
Chen, Y., Takita, J., Choi, Y. L., Kato, M., Ohira, M., Sanada, M., Wang, L., Soda, M., Kikuchi, A., Igarashi, T., et al. (2008) · Nature · doi:10.1038/nature07399 · Cited by 916
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
Activating mutations in ALK provide a therapeutic target in neuroblastoma
George, R. E., Sanda, T., Hanna, M., Fröhling, S., II, W. L., Zhang, J., Ahn, Y., Zhou, W., London, W. B., McGrady, P., et al. (2008) · Nature · doi:10.1038/nature07397 · Cited by 893
Shimada, H., Chatten, J., Newton, W. A., Sachs, N., Hamoudi, A. B., Chiba, T., Marsden, H. B., & Misugi, K. (1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/73.2.405 · Cited by 862
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., & Brodeur, G. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303253281205 · Cited by 694
Brodeur, G. M., Seeger, R. C., Barrett, A., Berthold, F., Castleberry, R. P., D'Angio, G., De Bernardi, B., Evans, A. E., Favrot, M., & Freeman, A. I. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.12.1874 · Cited by 608
(2007) · doi:10.1289/ehp.9023 · Cited by 591
London, W. B., Castleberry, R. P., Matthay, K. K., Look, A. T., Seeger, R. C., Shimada, H., Thorner, P., Brodeur, G., Maris, J. M., Reynolds, C. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.571 · Cited by 589
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
Attiyeh, E. F., London, W. B., Mossé, Y. P., Wang, Q., Winter, C., Khazi, D., McGrady, P. W., Seeger, R. C., Look, A. T., Shimada, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052399 · Cited by 580
Mesenchymal Stem Cell Features of Ewing Tumors
Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P., & Delattre, O. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.027 · Cited by 507
Eide, F. F., Vining, E. R., Eide, B. L., Zang, K., Wang, X.-Y., & Reichardt, L. F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03123.1996 · Cited by 474
Neuroblastoma Screening at One Year of Age
Schilling, F. H., Spix, C., Berthold, F., Erttmann, R., Fehse, N., Hero, B., Klein, G., Sander, J., Schwarz, K., Treuner, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012277 · Cited by 464
P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., & Ling, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252304 · Cited by 441
Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with Neuroblastoma
Caron, H. N., Sluis, P. V., de Kraker, J., Bökkerink, J. P. M., Egeler, M., Laureys, G., Slater, R. M., Westerveld, A., Voûte, P. A., & Versteeg, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340404 · Cited by 425
Self-citationExpression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara, A., Azar, C. G., Scavarda, N. J., & Brodeur, G. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.759 · Cited by 423
IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.
Jb, B., & Perrin, E. V. (1963) · PubMed · Cited by 403
Berthold, F., Boos, J., Burdach, S., Erttmann, R., Henze, G., Hermann, J., Klingebiel, T., Kremens, B., Schilling, F. H., Schrappe, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70291-6 · Cited by 402
SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSIS
D'Angio, G., Evans, A., & Koop, C. E. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91606-0 · Cited by 401
Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in Neuroblastoma
Trochet, D., Bourdeaut, F., Janoueix-Lerosey, I., Deville, A., de Pontual, L., Schleiermacher, G., Coze, C., Philip, N., Frébourg, T., Munnich, A., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/383253 · Cited by 358
Screening of Infants and Mortality Due to Neuroblastoma
Woods, W. G., Gao, R.-N., Shuster, J. J., Robison, L. L., Bernstein, M., Weitzman, S., Bunin, G., Levy, I., Brossard, J., Dougherty, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012387 · Cited by 356
Pathology of Tumours of the Nervous System
Timperley, W. (1989) · Journal of Clinical Pathology · doi:10.1136/jcp.42.12.1314-d · Cited by 356
Eggert, A., Ikegaki, N., Kwiatkowski, J. L., Zhao, H., Brodeur, G. M., & Himelstein, B. P. (2000) · PubMed · Cited by 353
Self-citationAllenspach, E. J., Maillard, I., Aster, J. C., & Pear, W. S. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.5.159 · Cited by 344
Meitar, D., Crawford, S. E., Rademaker, A. W., & Cohn, S. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.405 · Cited by 342
Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., & Haber, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340405 · Cited by 322
Germline PHOX2B Mutation in Hereditary Neuroblastoma
Mosse, Y. P., Laudenslager, M., Khazi, D., Carlisle, A. J., Winter, C. L., Rappaport, E., & Maris, J. M. (2004) · The American Journal of Human Genetics · doi:10.1086/424530 · Cited by 284
Castle, V. P., Heidelberger, K. P., Bromberg, J., Ou, X., Dole, M. G., & Núñez, G. (1993) · PubMed · Cited by 283
Hopkins-Donaldson, S., Bodmer, J.-L., Bourloud, K. B., Brognara, C. B., Tschopp, J., & Gross, N. (2000) · PubMed · Cited by 274
Biffo, S., Offenhäuser, N., Carter, B. D., & Barde, Y.-A. (1995) · Development · doi:10.1242/dev.121.8.2461 · Cited by 272
Eggert, A., Grotzer, M. A., Zuzak, T. J., Wiewrodt, B. R., Ho, R., Ikegaki, N., & Brodeur, G. M. (2001) · PubMed · Cited by 267
Self-citationPHOX2B Genotype Allows for Prediction of Tumor Risk in Congenital Central Hypoventilation Syndrome
Trochet, D., O'Brien, L. M., Gozal, D., Trang, H., Nordenskjöld, A., Laudier, B., Svensson, P.-J., Uhrig, S., Cole, T., Munnich, A., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/428366 · Cited by 250
Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschellà, G., & Persson, H. (1993) · PubMed · Cited by 247
Schmidt, M. L., Lukens, J. N., Seeger, R. C., Brodeur, G. M., Shimada, H., Gerbing, R. B., Stram, D. O., Perez, C., Haase, G. M., & Matthay, K. K. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1260 · Cited by 241
Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho, R., Eggert, A., Hishiki, T., Minturn, J. E., Ikegaki, N., Foster, P., Camoratto, A. M., Evans, A. E., & Brodeur, G. M. (2002) · PubMed · Cited by 228
Self-citationChantrain, C. F., Shimada, H., Jodele, S., Groshen, S., Ye, W., Shalinsky, D. R., Werb, Z., Coussens, L. M., & DeClerck, Y. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0160 · Cited by 218
Tacconelli, A., Farina, A. R., Cappabianca, L., DeSantis, G., Tessitore, A., Vetuschi, A., Sferra, R., Rucci, N., Argenti, B., Screpanti, I., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.011 · Cited by 208
George, R. E., Li, S., Medeiros-Nancarrow, C., Neuberg, D., Marcus, K., Shamberger, R. C., Pulsipher, M., Grupp, S. A., & Diller, L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6986 · Cited by 205
A Systematic Review of Molecular and Biological Tumor Markers in Neuroblastoma
Riley, R. D., Heney, D., Jones, D. R., Sutton, A. J., Lambert, P. C., Abrams, K. R., Young, B., Wailoo, A. J., & Burchill, S. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1051-2 · Cited by 203
Jaboin, J. J., Kim, C. J., Kaplan, D. R., & Thiele, C. J. (2002) · PubMed · Cited by 201
The biologic basis for neuroblastoma heterogeneity and risk stratification
Maris, J. M. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000150631.60571.89 · Cited by 201
Katzenstein, H. M., Bowman, L. C., Brodeur, G. M., Thorner, P. S., Joshi, V. V., Smith, E. I., Look, A. T., Rowe, S. T., Nash, M. B., Holbrook, T., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2007 · Cited by 190
Lack of High-Affinity Nerve Growth Factor Receptors in Aggressive Neuroblastomas
Suzuki, T., Bogenmann, E., Shimada, H., Stram, D., & Seeger, R. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.377 · Cited by 187
Pritchard, J., Cotterill, S. J., Germond, S. M., Imeson, J., de Kraker, J., & Jones, D. R. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20219 · Cited by 183
Haber, M., Smith, J., Bordow, S. B., Flemming, C., Cohn, S. L., London, W. B., Marshall, G. M., & Norris, M. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6196 · Cited by 177
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
Kushner, B. H., LaQuaglia, M. P., Bonilla, M. A., Lindsley, K., Rosenfield, N., Yeh, S., Eddy, J., Gerald, W. L., Heller, G., & Cheung, N. K. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2607 · Cited by 174
Genetic parameters of neuroblastomas
Westermann, F., & Schwab, M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00199-4 · Cited by 173
Expression of TrkA, TrkB and TrkC in human neuroblastomas
Brodeur, G. M., Nakagawara, A., Yamashiro, D. J., Ikegaki, N., Liu, X.-G., Azar, C. G., Lee, C. P., & Evans, A. E. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005729329526 · Cited by 172
Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study
Haas-Kogan, D. A., Swift, P. S., Selch, M., Haase, G. M., Seeger, R. C., Gerbing, R. B., Stram, D. O., & Matthay, K. K. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04506-6 · Cited by 170
van Noesel, M. M., van Bezouw, S., Salomons, G. S., Voûte, P. A., Pieters, R., Baylin, S. B., Herman, J. G., & Versteeg, R. (2002) · PubMed · Cited by 165
Jodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., Coussens, L. M., & DeClerck, Y. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3770 · Cited by 159
Truncated trkB.T1 Is Dominant Negative Inhibitor of trkB.TK+-Mediated Cell Survival
Haapasalo, A., Koponen, E., Hoppe, E., Wong, G., & Ċastrén, E. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4296 · Cited by 158
George, R. E., London, W. B., Cohn, S. L., Maris, J. M., Kretschmar, C. S., Diller, L., Brodeur, G. M., Castleberry, R. P., & Look, A. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.582 · Cited by 150
Schmidt, M. L., Lal, A., Seeger, R. C., Maris, J. M., Shimada, H., O’Leary, M., Gerbing, R. B., & Matthay, K. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.183 · Cited by 150
Familial neuroblastoma. Case reports, literature review, and etiologic considerations
Kushner, B. H., Gilbert, F., & Helson, L. (1986) · Cancer · Cited by 148
The Phox2B homeobox gene is mutated in sporadic neuroblastomas
van Limpt, V., Schramm, A. R., Lakeman, A., Sluis, P. V., Chan, A., van Noesel, M. M., Baas, F., Caron, H. N., Eggert, A., & Versteeg, R. (2004) · Oncogene · doi:10.1038/sj.onc.1208157 · Cited by 140
Self-citationKushner, B. H., Wolden, S. L., LaQuaglia, M. P., Kramer, K., Verbel, D., Heller, G., & Cheung, N. V. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2821 · Cited by 128
Efficacy of complete resection for high-risk neuroblastoma: a children’s cancer group study
Adkins, E. S., Sawin, R. S., Gerbing, R. B., London, W. B., Matthay, K. K., & Haase, G. M. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2004.02.041 · Cited by 123
Environmental risk factors for brain tumors
Connelly, J., & Malkin, M. G. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0032-4 · Cited by 105
Eggert, A., Grotzer, M. A., Ikegaki, N., Liu, X. G., Evans, A. E., & Brodeur, G. M. (2002) · PubMed · Cited by 100
Self-citationAoyama, M., Asai, K., Shishikura, T., Kawamoto, T., Miyachi, T., Yokoi, T., Togari, H., Wada, Y., Kato, T., & Nakagawara, A. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00715-1 · Cited by 95
Messina, J. A., Cheng, S., Franc, B. L., Charron, M., Shulkin, B. L., To, B., Maris, J. M., Yanik, G. A., Hawkins, R. A., & Matthay, K. K. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20777 · Cited by 89
Simon, T., Hero, B., Bongartz, R., Schmidt, M. C., Müller, R.-P., & Berthold, F. (2006) · Strahlentherapie und Onkologie · doi:10.1007/s00066-006-1498-8 · Cited by 84
Borrello, M. G., Bongarzone, I., Plerotti, M. A., Luksch, R., Gasparini, M., Collini, P., Pllotti, S., Rlzzetti, M. G., Mondellini, P., Bernardi, B. D., et al. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540404 · Cited by 80
Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
Scala, S., Wosikowski, K., Giannakakou, P., Valle, P., Biedler, J. L., Spengler, B. A., Lucarelli, E., Bates, S. E., & Thiele, C. J. (1996) · PubMed · Cited by 65
New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status.
Simon, T., Spitz, R., Faldum, A., Hero, B., & Berthold, F. (2004) · PubMed · Cited by 65
Clausen, N., Andersson, P., & Tommerup, N. (1989) · Acta Paediatrica · doi:10.1111/j.1651-2227.1989.tb11135.x · Cited by 61
Bradfield, S. M., Douglas, J. G., Hawkins, D. S., Sanders, J. E., & Park, J. R. (2004) · Cancer · doi:10.1002/cncr.20091 · Cited by 54
Self-citationNucleoside Diphosphate Kinase A/nm23-H1 Promotes Metastasis of NB69-Derived Human Neuroblastoma
Almgren, M., Henriksson, K. C. E., Fujimoto, J., & Chang, C. L. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.387.2.7 · Cited by 49
Wnt-5a gene expression in malignant human neuroblasts
Blanc, É., Goldschneider, D., Douc‐Rasy, S., Bénard, J., & Raguénez, G. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.11.061 · Cited by 42
Longo, L., Panza, E., Schena, F., Seri, M., Devoto, M., Romeo, G. C., Bini, C., Pappalardo, G., Tonini, G. P., & Perri, P. (2007) · Human Heredity · doi:10.1159/000099997 · Cited by 36
Cited by
The Hox genes and their roles in oncogenesis
Shah, N., & Sukumar, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2826 · Cited by 835
Irwin, M. S., & Park, J. R. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2014.09.015 · Cited by 392
Self-citationMolecular targeting therapies for neuroblastoma: Progress and challenges
Zafar, A., Wang, W., Liu, G., Wang, X., Xian, W., McKeon, F., Foster, J., Zhou, J., & Zhang, R. (2021) · Medicinal Research Reviews · doi:10.1002/med.21750 · Cited by 380
Mutational dynamics between primary and relapse neuroblastomas
Schramm, A., Köster, J., Assenov, Y., Althoff, K., Peifer, M., Mahlow, E., Odersky, A., Beisser, D., Ernst, C., Henssen, A. G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3349 · Cited by 304
Self-citationNeuroblastoma—A Neural Crest Derived Embryonal Malignancy
Johnsen, J. I., Dyberg, C., & Wickström, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00009 · Cited by 277
Metadata
- Authors
- Park, J. R., Eggert, A., & Caron, H.
- Venue
- Hematology/Oncology Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 24
- Issue
- 1
- Pages
- 65-86
- ISSN
- 0889-8588 (ISSN-L)
- OpenAlex
- W2063960043
- Cited by
- 620
- References
- 84
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.